Eli Lilly misses estimates for top-selling diabetes drug Trulicity, shares slip - KFGO News https://t.co/cZwZoftUe6 — IDRO (@IDROOhio) May 1, 2019
Eli Lilly misses estimates for top-selling diabetes drug Trulicity, shares slip - KFGO News https://t.co/cZwZoftUe6
No comments:
Post a Comment